Your browser doesn't support javascript.
loading
The expression of LRRN4 was correlated with the progression and prognosis of colon adenocarcinoma (COAD) patients.
Zhang, Yuxian; Xie, Jianlan; Liu, Diangang; Zhu, Shengtao; Zhang, Shutian.
Afiliação
  • Zhang Y; Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing Digestive Disease Center, National Clinical Research Center for Digestive Disease, Capital Medical University, Beijing Friendship Hospital, Department of Gastroenterology, Beijing, P. R. China.
  • Xie J; Capital Medical University, Beijing Friendship Hospital, Department of Pathology, Beijing, P.R. China.
  • Liu D; Xuanwu Hospital, Capital Medical University, Department of General Surgery, Beijing, P. R. China.
  • Zhu S; Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing Digestive Disease Center, National Clinical Research Center for Digestive Disease, Capital Medical University, Beijing Friendship Hospital, Department of Gastroenterology, Beijing, P. R. China.
  • Zhang S; Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing Digestive Disease Center, National Clinical Research Center for Digestive Disease, Capital Medical University, Beijing Friendship Hospital, Department of Gastroenterology, Beijing, P. R. China.
Genet Mol Biol ; 45(1): e20210138, 2021.
Article em En | MEDLINE | ID: mdl-34919118
ABSTRACT
Our present study aims to investigate the value of LRRN4 in the progression and prognosis of COAD patients. All COAD and adjacent sample data was downloaded from TCGA database. Survival analysis was performed according to Kaplan-Meier method. The real-time quantitative PCR and immunohistochemistry analysis were conducted for validation in cell lines and tissues. The GSEA was conducted to find functional KEGG pathways. Multivariate Cox regression proportional hazard mode was used to determine whether LRRN4 expression was an independent prognostic factor. The LRRN4 expression in COAD samples were significantly higher than that in adjacent samples, which was consistent with our experiments in cell lines and tissues. Along with the increase of TNM Stage, LRRN4 expression had an increasing tendency. The COAD patients with high LRRN4 expression showed undesirable prognoses. Additionally, the TGF-ß signaling pathway, WNT signaling pathway and other 25 pathways were significantly activated in the high LRRN4 expression group. In conclusion, high LRRN4 expression was closely related to the onset of COAD and it was a poor prognostic factor for COAD patients.